1. 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir. (15th December 2022) Authors: Singh, Kanal; Rubenstein, Kevin; Callier, Viviane; Shaw-Saliba, Katy; Rupert, Adam; Dewar, Robin L; Laverdure, Sylvain; Highbarger, Helene; Lallemand, Perrine; Huang, Meei-Li; Jerome, Keith R; Sampoleo, Reigran; Mills, Margaret; Porter, Danielle P; Juneja, Kavita; Greninger, Alexander L; Clifford... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗